These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11430580)

  • 1. Neuropharmacological analysis of the role of the serotoninergic system in forming hyperalgesia in neurotic rats.
    Kudryashova MF; Andreev BV
    Neurosci Behav Physiol; 2001; 31(3):333-4. PubMed ID: 11430580
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neuropharmacological analysis of participation of the serotoninergic system in hyperalgesia in neurotized rats].
    Kudriashova MF; Andreev BV
    Ross Fiziol Zh Im I M Sechenova; 2000 Feb; 86(2):216-8. PubMed ID: 10808514
    [No Abstract]   [Full Text] [Related]  

  • 3. Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its actions.
    Gobert A; Rivet JM; Cistarelli L; Melon C; Millan MJ
    Neuroscience; 1999; 93(4):1251-62. PubMed ID: 10501449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal Stimulation of 5-HT
    Mikhailenko VA; Butkevich IP
    Bull Exp Biol Med; 2019 Jan; 166(3):306-309. PubMed ID: 30656521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonergic signaling inhibits hyperalgesia induced by spinal cord damage.
    Horiuchi H; Ogata T; Morino T; Takeba J; Yamamoto H
    Brain Res; 2003 Feb; 963(1-2):312-20. PubMed ID: 12560138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of various serotonergic agents on alcohol intake and alcohol preference in Wistar rats selected at two different levels of alcohol preference.
    Meert TF
    Alcohol Alcohol; 1993 Mar; 28(2):157-70. PubMed ID: 8517886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 5-HT1A receptor antagonists on fluoxetine-induced changes in extracellular serotonin concentrations in rat frontal cortex.
    Dawson LA; Nguyen HQ
    Eur J Pharmacol; 1998 Mar; 345(1):41-6. PubMed ID: 9593592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose dependent effects of serotonergic agents on anxiety.
    Kolcsar M; Gáll Z; Dogaru MT
    Acta Physiol Hung; 2014 Dec; 101(4):479-87. PubMed ID: 25532957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of flibanserin (BIMT 17), fluoxetine, 8-OH-DPAT and buspirone on serotonin synthesis in rat brain.
    Brambilla A; Baschirotto A; Grippa N; Borsini F
    Eur Neuropsychopharmacol; 1999 Dec; 10(1):63-7. PubMed ID: 10647099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buspirone enhances duloxetine- and fluoxetine-induced increases in dialysate levels of dopamine and noradrenaline, but not serotonin, in the frontal cortex of freely moving rats.
    Gobert A; Rivet JM; Cistarelli JM; Millan MJ
    J Neurochem; 1997 Mar; 68(3):1326-9. PubMed ID: 9048781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tandospirone potentiates the fluoxetine-induced increases in extracellular dopamine via 5-HT(1A) receptors in the rat medial frontal cortex.
    Yoshino T; Nisijima K; Katoh S; Yui K; Nakamura M
    Neurochem Int; 2002 Apr; 40(4):355-60. PubMed ID: 11792466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of hippocampal serotonergic neurons in ischemic neuronal death.
    Nakata N; Suda H; Izumi J; Tanaka Y; Ikeda Y; Kato H; Itoyama Y; Kogure K
    Behav Brain Res; 1997 Feb; 83(1-2):217-20. PubMed ID: 9062688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The serotonergic system may be involved in the sleep-inducing action of oleamide in rats.
    Yang JY; Wu CF; Wang F; Song HR; Pan WJ; Wang YL
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):457-62. PubMed ID: 14615880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects on nociception of the Ca2+ and 5-HT antagonist dotarizine and other 5-HT receptor agonists and antagonists.
    Belcheva S; Petkov VD; Konstantinova E; Petkov VV; Boyanova E
    Acta Physiol Pharmacol Bulg; 1995; 21(4):93-8. PubMed ID: 8830881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of fluoxetine and buspirone on the panicolytic-like response induced by the activation of 5-HT1A and 5-HT2A receptors in the rat dorsal periaqueductal gray.
    de Bortoli VC; Nogueira RL; Zangrossi H
    Psychopharmacology (Berl); 2006 Jan; 183(4):422-8. PubMed ID: 16258751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manipulation of operant responding for an ethanol-paired conditioned stimulus in the rat by pharmacological alteration of the serotonergic system.
    Wilson AW; Costall B; Neill JC
    J Psychopharmacol; 2000; 14(4):340-6. PubMed ID: 11198050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.
    De Vry J; Schreiber R; Melon C; Dalmus M; Jentzsch KR
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):487-95. PubMed ID: 15589388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for accelerated desensitisation of 5-HT(2C) receptors following combined treatment with fluoxetine and the 5-HT(1A) receptor antagonist, WAY 100,635, in the rat.
    Bristow LJ; O'Connor D; Watts R; Duxon MS; Hutson PH
    Neuropharmacology; 2000 Apr; 39(7):1222-36. PubMed ID: 10760364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the participation of peripheral 5-HT₂A, 5-HT₂B, and 5-HT₂C receptors in formalin-induced secondary mechanical allodynia and hyperalgesia.
    Cervantes-Durán C; Pineda-Farias JB; Bravo-Hernández M; Quiñonez-Bastidas GN; Vidal-Cantú GC; Barragán-Iglesias P; Granados-Soto V
    Neuroscience; 2013 Mar; 232():169-81. PubMed ID: 23219842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of learned helplessness by selective serotonin reuptake inhibitors in rats is not dependent on 5-HT availability.
    Zazpe A; Artaiz I; Labeaga L; Lucero ML; Orjales A
    Neuropharmacology; 2007 Mar; 52(3):975-84. PubMed ID: 17141811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.